Compositions and methods for generating an immune response to hepatitis B virus
US11052148B2 · kind B2 · utility
2Cited by
1References
11Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | May 30, 2017 |
| Grant date | Jul 6, 2021 |
| Priority date | — |
| Expiry date | May 30, 2037 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2730/10134
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The compositions and methods are described for generating an immune response to a hepatitis B virus. The compositions and methods described herein relate to a modified vaccinia Ankara (MVA) vector encoding one or more viral antigens for generating a protective immune response to a hepatitis B virus, in the subject to which the vector is administered. The compositions and methods of the present invention are useful both prophylactically and therapeutically and may be used to prevent and/or treat an infection caused by hepatitis B virus.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.